Radiation oncology firm Accuray has secured a $40 million term loan with MidCap Financial Trust.
The agreement concurrently applies $20 million to the company's existing revolving loan with MidCap.
Accuray intends to use the net proceeds of the loan, along with existing cash, to retire the $40 million aggregate principal amount of its convertible senior notes and series A convertible senior notes due February 1, 2018, it said.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
